{"id":24518,"date":"2025-06-05T13:06:32","date_gmt":"2025-06-05T11:06:32","guid":{"rendered":"https:\/\/www.investincotedazur.com\/?p=24518"},"modified":"2025-09-05T09:25:31","modified_gmt":"2025-09-05T07:25:31","slug":"the-nice-based-biotech-company-roca-therapeutics-receives-financial-support-from-europe-and-the-sud-region-for-its-medical-research-in-eye-health","status":"publish","type":"post","link":"https:\/\/www.investincotedazur.com\/en\/the-nice-based-biotech-company-roca-therapeutics-receives-financial-support-from-europe-and-the-sud-region-for-its-medical-research-in-eye-health\/","title":{"rendered":"The Nice-based biotech company Roca Therapeutics receives financial support from Europe and the SUD region for its medical research in eye health"},"content":{"rendered":"\n<div class=\"wp-container-3 wp-block-columns\">\n<div class=\"wp-container-1 wp-block-column\" style=\"flex-basis:33.33%\">\n<figure class=\"wp-block-image size-large is-resized\"><img src=\"https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2025\/06\/Copie-de-investincotedazur-54-819x1024.png\" alt=\"biotech ni\u00e7oise Roca Therapeutics\" class=\"wp-image-23389\" width=\"233\" height=\"292\" srcset=\"https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2025\/06\/Copie-de-investincotedazur-54-819x1024.png 819w, https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2025\/06\/Copie-de-investincotedazur-54-240x300.png 240w, https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2025\/06\/Copie-de-investincotedazur-54-768x960.png 768w, https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2025\/06\/Copie-de-investincotedazur-54.png 1080w\" sizes=\"(max-width: 233px) 100vw, 233px\" \/><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-container-2 wp-block-column\" style=\"flex-basis:66.66%\">\n<ul class=\"has-medium-font-size\"><li>Major public funding for the Nice biotech: <a href=\"https:\/\/www.roca-therapeutics.org\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\"><u>Roca Therapeutics<\/u><\/a> receives over \u20ac1.1 million through the European program FEDER-FSE+-FTJ 2021\u20132027, co-funded by the European Union and the SUD Region.<\/li><li>An innovative eye health project: RCT002 is an innovative non-invasive eye drop treatment for rare and debilitating ocular diseases such as radiation maculopathy and diabetic macular edema.<\/li><li>A mobilized regional ecosystem: the project is supported by Eurobiomed, the accounting firm DSO, and their legal counsel Me Graziani, with strong ties to the health innovation ecosystem of the Nice C\u00f4te d\u2019Azur Metropolis.<\/li><\/ul>\n<\/div>\n<\/div>\n\n\n\n<h2><strong>Targeted public support for health innovation<\/strong><\/h2>\n\n\n\n<p>The local biomedical innovation network is strengthened through the financial support granted to Roca Therapeutics, a biotech company based in the Nice C\u00f4te d\u2019Azur Metropolis. <a href=\"https:\/\/www.investincotedazur.com\/roca-therapeutics-candidat-medicament\/\"><u>The company, co-founded by Zaki Sellam, Cyril Ronco, Rachid Benhida, Gilles Pag\u00e8s, and Maeva Dufies<\/u><\/a>, was selected as part of the European program Provence-Alpes-C\u00f4te d\u2019Azur and Massif des Alpes FEDER-FSE+-FTJ 2021\u20132027, a strategic lever for regional innovation funding.<\/p>\n\n\n\n<p>The allocated amount \u2014 \u20ac1,106,120.40 \u2014 is co-funded by the European Union through the European Regional Development Fund (ERDF) and the SUD Region \u2013 Provence-Alpes-C\u00f4te d\u2019Azur. This funding is part of a total budget of \u20ac1,580,172 (excluding taxes) dedicated to the implementation of the RCT002 project. The project focuses on the development of a non-invasive ophthalmic drug.  <\/p>\n\n\n\n<p>The initiative is led regionally by the FEDER Sud team, in collaboration with the \u201cEurope in the South\u201d platform, responsible for promoting innovative projects benefiting from European funding.<\/p>\n\n\n\n<div style=\"height:48px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2><strong>A non-invasive approach for orphan diseases<\/strong><\/h2>\n\n\n\n<p>The RCT002 project aims to develop an innovative eye drop targeting neovascular ocular diseases, primarily radiation maculopathy \u2014 a severe complication affecting over half of patients treated with radiotherapy\/proton therapy for uveal melanoma, a rare eye cancer.<\/p>\n\n\n\n<p>This condition is characterized by the formation of abnormal blood vessels in the retina, causing macular edema that leads to progressive, and sometimes irreversible, loss of central vision. Current treatments rely on frequent intraocular injections, which are not approved at the European level, are physically and mentally burdensome, and often ineffective in the long term. <\/p>\n\n\n\n<p>In response to this situation, Roca Therapeutics is introducing a breakthrough technology. The RCT002 eye drop targets new therapeutic mechanisms, offering a non-invasive, at-home treatment that reduces hospitalization risks and improves patient compliance. <\/p>\n\n\n\n<div style=\"height:48px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2><strong>A structured, supported, and locally rooted project<\/strong><\/h2>\n\n\n\n<p>The RCT002 program is scheduled over a 28-month period (January 2024 to April 2026) and aims for three main deliverables:<\/p>\n\n\n\n<ul><li>Completion of preclinical studies,<\/li><li>Evaluation of the product for related indications, notably diabetic macular edema,<\/li><li>Pre-industrialization of the compound, a necessary step before launching the first clinical trials.<\/li><\/ul>\n\n\n\n<p><\/p>\n\n\n\n<p>The stated goal is to enter clinical phase (1b\/2a) within 12 months.<\/p>\n\n\n\n<p>To secure both scientific and industrial milestones, Roca Therapeutics is supported by the Eurobiomed competitiveness cluster, a key player in health innovation in the Greater South region. Additionally, Axess D\u00e9veloppement, a specialist in the structuring of complex technological projects, provides operational support. <\/p>\n\n\n\n<div style=\"height:48px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p><\/p>\n\n\n\n<p>Source \/ More information :<a href=\"https:\/\/www.linkedin.com\/posts\/roca-therapeutics_feder-activity-7322614118165745664-L4pW?utm_source=share&amp;utm_medium=member_desktop&amp;rcm=ACoAAAmzITsBG_nQIEGhAx2NjoFDc_VOqaJJFX4\"> <\/a><a href=\"https:\/\/www.linkedin.com\/posts\/roca-therapeutics_feder-activity-7322614118165745664-L4pW?utm_source=share&amp;utm_medium=member_desktop&amp;rcm=ACoAAAmzITsBG_nQIEGhAx2NjoFDc_VOqaJJFX4\" target=\"_blank\" rel=\"noreferrer noopener nofollow\"><u>https:\/\/www.linkedin.com\/posts\/roca-therapeutics_feder-activity-7322614118165745664-L4pW?utm_source=share&amp;utm_medium=member_desktop&amp;rcm=ACoAAAmzITsBG_nQIEGhAx2NjoFDc_VOqaJJFX4<\/u><\/a><\/p>\n\n\n\n<div style=\"height:48px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2>Biotech Nice C\u00f4te d&#8217;Azur<\/h2>\n\n\n<ul class=\"wp-block-latest-posts__list is-grid columns-2 wp-block-latest-posts\"><li><div class=\"wp-block-latest-posts__featured-image alignleft\"><a href=\"https:\/\/www.investincotedazur.com\/en\/obesity-french-first-at-nice-university-hospital\/\" aria-label=\"Obesity: French first at Nice University Hospital\"><img width=\"150\" height=\"150\" src=\"https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2026\/04\/obesite-chu-de-nice-150x150.jpg\" class=\"attachment-thumbnail size-thumbnail wp-post-image\" alt=\"Obseite CHU de Nice\" style=\"max-width:50px;max-height:50px;\" loading=\"lazy\" srcset=\"https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2026\/04\/obesite-chu-de-nice-150x150.jpg 150w, https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2026\/04\/obesite-chu-de-nice-300x300.jpg 300w, https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2026\/04\/obesite-chu-de-nice.jpg 700w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/a><\/div><a class=\"wp-block-latest-posts__post-title\" href=\"https:\/\/www.investincotedazur.com\/en\/obesity-french-first-at-nice-university-hospital\/\">Obesity: French first at Nice University Hospital<\/a><\/li>\n<li><div class=\"wp-block-latest-posts__featured-image alignleft\"><a href=\"https:\/\/www.investincotedazur.com\/en\/team-nice-cote-dazur-at-the-van-lanschot-kempen-life-sciences-conference-2026\/\" aria-label=\"Team Nice C\u00f4te d\u2019Azur at the Van Lanschot Kempen Life Sciences Conference 2026\"><img width=\"150\" height=\"150\" src=\"https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2026\/04\/Nice-Cote-dAzur-a-la-Van-Lanschot-Kempen-Life-Sciences-Conference-2026-150x150.png\" class=\"attachment-thumbnail size-thumbnail wp-post-image\" alt=\"Nice C\u00f4te d\u2019Azur \u00e0 la Van Lanschot Kempen Life Sciences Conference 2026\" style=\"max-width:50px;max-height:50px;\" loading=\"lazy\" srcset=\"https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2026\/04\/Nice-Cote-dAzur-a-la-Van-Lanschot-Kempen-Life-Sciences-Conference-2026-150x150.png 150w, https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2026\/04\/Nice-Cote-dAzur-a-la-Van-Lanschot-Kempen-Life-Sciences-Conference-2026-700x700.png 700w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/a><\/div><a class=\"wp-block-latest-posts__post-title\" href=\"https:\/\/www.investincotedazur.com\/en\/team-nice-cote-dazur-at-the-van-lanschot-kempen-life-sciences-conference-2026\/\">Team Nice C\u00f4te d\u2019Azur at the Van Lanschot Kempen Life Sciences Conference 2026<\/a><\/li>\n<li><div class=\"wp-block-latest-posts__featured-image alignleft\"><a href=\"https:\/\/www.investincotedazur.com\/en\/launch-of-the-azur-territorial-research-entity-to-advance-clinical-research-on-the-french-riviera\/\" aria-label=\"Launch of the AZUR Territorial Research Entity to advance clinical research on the French Riviera\"><img width=\"150\" height=\"150\" src=\"https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2026\/04\/Creation-de-lEntite-de-Recherche-Territoriale-AZUR-150x150.png\" class=\"attachment-thumbnail size-thumbnail wp-post-image\" alt=\"Cr\u00e9ation de l\u2019Entit\u00e9 de Recherche Territoriale AZUR\" style=\"max-width:50px;max-height:50px;\" loading=\"lazy\" srcset=\"https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2026\/04\/Creation-de-lEntite-de-Recherche-Territoriale-AZUR-150x150.png 150w, https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2026\/04\/Creation-de-lEntite-de-Recherche-Territoriale-AZUR-700x700.png 700w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/a><\/div><a class=\"wp-block-latest-posts__post-title\" href=\"https:\/\/www.investincotedazur.com\/en\/launch-of-the-azur-territorial-research-entity-to-advance-clinical-research-on-the-french-riviera\/\">Launch of the AZUR Territorial Research Entity to advance clinical research on the French Riviera<\/a><\/li>\n<li><div class=\"wp-block-latest-posts__featured-image alignleft\"><a href=\"https:\/\/www.investincotedazur.com\/en\/bio-europe-spring-2026\/\" aria-label=\"BIO-Europe Spring 2026 : meet with Team Nice C\u00f4te d&#8217;Azur\"><img width=\"150\" height=\"150\" src=\"https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2026\/03\/bio-europe-lisbon-150x150.png\" class=\"attachment-thumbnail size-thumbnail wp-post-image\" alt=\"\" style=\"max-width:50px;max-height:50px;\" loading=\"lazy\" srcset=\"https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2026\/03\/bio-europe-lisbon-150x150.png 150w, https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2026\/03\/bio-europe-lisbon-700x700.png 700w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/a><\/div><a class=\"wp-block-latest-posts__post-title\" href=\"https:\/\/www.investincotedazur.com\/en\/bio-europe-spring-2026\/\">BIO-Europe Spring 2026 : meet with Team Nice C\u00f4te d&#8217;Azur<\/a><\/li>\n<li><div class=\"wp-block-latest-posts__featured-image alignleft\"><a href=\"https:\/\/www.investincotedazur.com\/en\/eurobiomed-more-than-e300-million-secured-in-2025-in-the-sud-and-occitanie-regions-by-eurobiomed-member-healthcare-companies\/\" aria-label=\"Eurobiomed: more than \u20ac300 million secured in 2025 in the Sud and Occitanie regions by Eurobiomed member healthcare companies\"><img width=\"150\" height=\"150\" src=\"https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2026\/02\/investincotedazur-2026-02-16T145753.925-150x150.jpg\" class=\"attachment-thumbnail size-thumbnail wp-post-image\" alt=\"eurobiomed 2025\" style=\"max-width:50px;max-height:50px;\" loading=\"lazy\" srcset=\"https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2026\/02\/investincotedazur-2026-02-16T145753.925-150x150.jpg 150w, https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2026\/02\/investincotedazur-2026-02-16T145753.925-300x300.jpg 300w, https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2026\/02\/investincotedazur-2026-02-16T145753.925.jpg 700w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/a><\/div><a class=\"wp-block-latest-posts__post-title\" href=\"https:\/\/www.investincotedazur.com\/en\/eurobiomed-more-than-e300-million-secured-in-2025-in-the-sud-and-occitanie-regions-by-eurobiomed-member-healthcare-companies\/\">Eurobiomed: more than \u20ac300 million secured in 2025 in the Sud and Occitanie regions by Eurobiomed member healthcare companies<\/a><\/li>\n<li><div class=\"wp-block-latest-posts__featured-image alignleft\"><a href=\"https:\/\/www.investincotedazur.com\/en\/team-nice-cote-dazur-showcases-ai-ecosystem-at-ai-business-tour-and-waicf-2026\/\" aria-label=\"Artificial intelligence: Team Nice C\u00f4te d\u2019Azur mobilized for an AI Business Tour and WAICF 2026\"><img width=\"150\" height=\"150\" src=\"https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2026\/02\/investincotedazur-72-150x150.png\" class=\"attachment-thumbnail size-thumbnail wp-post-image\" alt=\"eam Nice C\u00f4te d\u2019Azur mobilized for an AI Business Tour and WAICF 2026\" style=\"max-width:50px;max-height:50px;\" loading=\"lazy\" srcset=\"https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2026\/02\/investincotedazur-72-150x150.png 150w, https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2026\/02\/investincotedazur-72-700x700.png 700w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/a><\/div><a class=\"wp-block-latest-posts__post-title\" href=\"https:\/\/www.investincotedazur.com\/en\/team-nice-cote-dazur-showcases-ai-ecosystem-at-ai-business-tour-and-waicf-2026\/\">Artificial intelligence: Team Nice C\u00f4te d\u2019Azur mobilized for an AI Business Tour and WAICF 2026<\/a><\/li>\n<li><div class=\"wp-block-latest-posts__featured-image alignleft\"><a href=\"https:\/\/www.investincotedazur.com\/en\/nice-university-hospital-cooperation-emirates-hospitals-group-dubai\/\" aria-label=\"Nice University Hospital signs an international cooperation agreement with Emirates Hospitals Group (Dubai)\"><img width=\"150\" height=\"150\" src=\"https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2026\/02\/chu-nice-dubai-cooperation-150x150.jpg\" class=\"attachment-thumbnail size-thumbnail wp-post-image\" alt=\"chu nice dubai cooperation\" style=\"max-width:50px;max-height:50px;\" loading=\"lazy\" srcset=\"https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2026\/02\/chu-nice-dubai-cooperation-150x150.jpg 150w, https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2026\/02\/chu-nice-dubai-cooperation-300x300.jpg 300w, https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2026\/02\/chu-nice-dubai-cooperation.jpg 700w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/a><\/div><a class=\"wp-block-latest-posts__post-title\" href=\"https:\/\/www.investincotedazur.com\/en\/nice-university-hospital-cooperation-emirates-hospitals-group-dubai\/\">Nice University Hospital signs an international cooperation agreement with Emirates Hospitals Group (Dubai)<\/a><\/li>\n<li><div class=\"wp-block-latest-posts__featured-image alignleft\"><a href=\"https:\/\/www.investincotedazur.com\/en\/affluent-medical-acquires-caranx-medical-cardiac-robotics-ai\/\" aria-label=\"Caranx Medical, a Nice-based cardiac robotics MedTech startup, set to be acquired for \u20ac16.6 million\"><img width=\"150\" height=\"150\" src=\"https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2025\/07\/caranx-medical-TAVIPILOT-Soft-150x150.jpg\" class=\"attachment-thumbnail size-thumbnail wp-post-image\" alt=\"caranx medical TAVIPILOT Soft\" style=\"max-width:50px;max-height:50px;\" loading=\"lazy\" srcset=\"https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2025\/07\/caranx-medical-TAVIPILOT-Soft-150x150.jpg 150w, https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2025\/07\/caranx-medical-TAVIPILOT-Soft-300x300.jpg 300w, https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2025\/07\/caranx-medical-TAVIPILOT-Soft.jpg 700w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/a><\/div><a class=\"wp-block-latest-posts__post-title\" href=\"https:\/\/www.investincotedazur.com\/en\/affluent-medical-acquires-caranx-medical-cardiac-robotics-ai\/\">Caranx Medical, a Nice-based cardiac robotics MedTech startup, set to be acquired for \u20ac16.6 million<\/a><\/li>\n<li><div class=\"wp-block-latest-posts__featured-image alignleft\"><a href=\"https:\/\/www.investincotedazur.com\/en\/avc-continues-its-expansion-with-a-consolidated-base-in-the-cote-dazur\/\" aria-label=\"AVC continues its expansion with a consolidated base in the C\u00f4te d\u2019Azur\"><img width=\"150\" height=\"150\" src=\"https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2026\/01\/AVC-board-150x150.png\" class=\"attachment-thumbnail size-thumbnail wp-post-image\" alt=\"\" style=\"max-width:50px;max-height:50px;\" loading=\"lazy\" \/><\/a><\/div><a class=\"wp-block-latest-posts__post-title\" href=\"https:\/\/www.investincotedazur.com\/en\/avc-continues-its-expansion-with-a-consolidated-base-in-the-cote-dazur\/\">AVC continues its expansion with a consolidated base in the C\u00f4te d\u2019Azur<\/a><\/li>\n<li><div class=\"wp-block-latest-posts__featured-image alignleft\"><a href=\"https:\/\/www.investincotedazur.com\/en\/new-medical-governance-at-chu-de-nice\/\" aria-label=\"New medical governance at CHU de Nice\"><img width=\"150\" height=\"150\" src=\"https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2025\/11\/gouvernance-medicale-chu-nice-150x150.jpg\" class=\"attachment-thumbnail size-thumbnail wp-post-image\" alt=\"gouvernance medicale chu nice\" style=\"max-width:50px;max-height:50px;\" loading=\"lazy\" srcset=\"https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2025\/11\/gouvernance-medicale-chu-nice-150x150.jpg 150w, https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2025\/11\/gouvernance-medicale-chu-nice-300x300.jpg 300w, https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2025\/11\/gouvernance-medicale-chu-nice.jpg 700w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/a><\/div><a class=\"wp-block-latest-posts__post-title\" href=\"https:\/\/www.investincotedazur.com\/en\/new-medical-governance-at-chu-de-nice\/\">New medical governance at CHU de Nice<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>Major public funding for the Nice biotech: Roca Therapeutics receives over \u20ac1.1 million through the European program FEDER-FSE+-FTJ 2021\u20132027, co-funded by the European Union and the SUD Region. An innovative eye health project: RCT002 is an innovative non-invasive eye drop treatment for rare and debilitating ocular diseases such as radiation maculopathy and diabetic macular edema. [&hellip;]<\/p>\n","protected":false},"author":14,"featured_media":23390,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_mi_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0},"categories":[139,102,108],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v19.12 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>The Nice-based biotech company Roca Therapeutics receives financial support from Europe and the SUD region for its medical research in eye health - Invest in C\u00f4te d&#039;Azur<\/title>\n<meta name=\"description\" content=\"Roca Therapeutics receives over \u20ac1.1 million under the FEDER-FSE+ program to develop a non-invasive eye drop for rare ocular diseases, supporting regional biomedical innovation.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.investincotedazur.com\/en\/the-nice-based-biotech-company-roca-therapeutics-receives-financial-support-from-europe-and-the-sud-region-for-its-medical-research-in-eye-health\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The Nice-based biotech company Roca Therapeutics receives financial support from Europe and the SUD region for its medical research in eye health - Invest in C\u00f4te d&#039;Azur\" \/>\n<meta property=\"og:description\" content=\"Roca Therapeutics receives over \u20ac1.1 million under the FEDER-FSE+ program to develop a non-invasive eye drop for rare ocular diseases, supporting regional biomedical innovation.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.investincotedazur.com\/en\/the-nice-based-biotech-company-roca-therapeutics-receives-financial-support-from-europe-and-the-sud-region-for-its-medical-research-in-eye-health\/\" \/>\n<meta property=\"og:site_name\" content=\"Invest in C\u00f4te d&#039;Azur\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-05T11:06:32+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-05T07:25:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2025\/06\/Copie-de-investincotedazur-54-819x1024.png\" \/>\n\t<meta property=\"og:image:width\" content=\"819\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Jose Perez Gabarron\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@Investcotedazur\" \/>\n<meta name=\"twitter:site\" content=\"@Investcotedazur\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jose Perez Gabarron\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.investincotedazur.com\/en\/the-nice-based-biotech-company-roca-therapeutics-receives-financial-support-from-europe-and-the-sud-region-for-its-medical-research-in-eye-health\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.investincotedazur.com\/en\/the-nice-based-biotech-company-roca-therapeutics-receives-financial-support-from-europe-and-the-sud-region-for-its-medical-research-in-eye-health\/\"},\"author\":{\"name\":\"Jose Perez Gabarron\",\"@id\":\"https:\/\/www.investincotedazur.com\/en\/#\/schema\/person\/ebbeede4229d29e0861488f2bd1036d9\"},\"headline\":\"The Nice-based biotech company Roca Therapeutics receives financial support from Europe and the SUD region for its medical research in eye health\",\"datePublished\":\"2025-06-05T11:06:32+00:00\",\"dateModified\":\"2025-09-05T07:25:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.investincotedazur.com\/en\/the-nice-based-biotech-company-roca-therapeutics-receives-financial-support-from-europe-and-the-sud-region-for-its-medical-research-in-eye-health\/\"},\"wordCount\":538,\"publisher\":{\"@id\":\"https:\/\/www.investincotedazur.com\/en\/#organization\"},\"articleSection\":[\"Biotechnologies\",\"Nice C\u00f4te d'Azur Metropolis\",\"Startups\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.investincotedazur.com\/en\/the-nice-based-biotech-company-roca-therapeutics-receives-financial-support-from-europe-and-the-sud-region-for-its-medical-research-in-eye-health\/\",\"url\":\"https:\/\/www.investincotedazur.com\/en\/the-nice-based-biotech-company-roca-therapeutics-receives-financial-support-from-europe-and-the-sud-region-for-its-medical-research-in-eye-health\/\",\"name\":\"The Nice-based biotech company Roca Therapeutics receives financial support from Europe and the SUD region for its medical research in eye health - Invest in C\u00f4te d&#039;Azur\",\"isPartOf\":{\"@id\":\"https:\/\/www.investincotedazur.com\/en\/#website\"},\"datePublished\":\"2025-06-05T11:06:32+00:00\",\"dateModified\":\"2025-09-05T07:25:31+00:00\",\"description\":\"Roca Therapeutics receives over \u20ac1.1 million under the FEDER-FSE+ program to develop a non-invasive eye drop for rare ocular diseases, supporting regional biomedical innovation.\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.investincotedazur.com\/en\/the-nice-based-biotech-company-roca-therapeutics-receives-financial-support-from-europe-and-the-sud-region-for-its-medical-research-in-eye-health\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.investincotedazur.com\/en\/#website\",\"url\":\"https:\/\/www.investincotedazur.com\/en\/\",\"name\":\"Invest in C\u00f4te d'Azur\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.investincotedazur.com\/en\/#organization\"},\"alternateName\":\"Invest in C\u00f4te d'Azur\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.investincotedazur.com\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.investincotedazur.com\/en\/#organization\",\"name\":\"Invest in C\u00f4te d'Azur\",\"alternateName\":\"Invest in C\u00f4te d'Azur\",\"url\":\"https:\/\/www.investincotedazur.com\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.investincotedazur.com\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2023\/05\/cropped-New-missions-3.png\",\"contentUrl\":\"https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2023\/05\/cropped-New-missions-3.png\",\"width\":512,\"height\":512,\"caption\":\"Invest in C\u00f4te d'Azur\"},\"image\":{\"@id\":\"https:\/\/www.investincotedazur.com\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/investincotedazur\/\",\"https:\/\/twitter.com\/Investcotedazur\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.investincotedazur.com\/en\/#\/schema\/person\/ebbeede4229d29e0861488f2bd1036d9\",\"name\":\"Jose Perez Gabarron\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.investincotedazur.com\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/20ec9e74f48620b8ee4253da6b114950?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/20ec9e74f48620b8ee4253da6b114950?s=96&d=mm&r=g\",\"caption\":\"Jose Perez Gabarron\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The Nice-based biotech company Roca Therapeutics receives financial support from Europe and the SUD region for its medical research in eye health - Invest in C\u00f4te d&#039;Azur","description":"Roca Therapeutics receives over \u20ac1.1 million under the FEDER-FSE+ program to develop a non-invasive eye drop for rare ocular diseases, supporting regional biomedical innovation.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.investincotedazur.com\/en\/the-nice-based-biotech-company-roca-therapeutics-receives-financial-support-from-europe-and-the-sud-region-for-its-medical-research-in-eye-health\/","og_locale":"en_US","og_type":"article","og_title":"The Nice-based biotech company Roca Therapeutics receives financial support from Europe and the SUD region for its medical research in eye health - Invest in C\u00f4te d&#039;Azur","og_description":"Roca Therapeutics receives over \u20ac1.1 million under the FEDER-FSE+ program to develop a non-invasive eye drop for rare ocular diseases, supporting regional biomedical innovation.","og_url":"https:\/\/www.investincotedazur.com\/en\/the-nice-based-biotech-company-roca-therapeutics-receives-financial-support-from-europe-and-the-sud-region-for-its-medical-research-in-eye-health\/","og_site_name":"Invest in C\u00f4te d&#039;Azur","article_published_time":"2025-06-05T11:06:32+00:00","article_modified_time":"2025-09-05T07:25:31+00:00","og_image":[{"width":819,"height":1024,"url":"https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2025\/06\/Copie-de-investincotedazur-54-819x1024.png","type":"image\/png"}],"author":"Jose Perez Gabarron","twitter_card":"summary_large_image","twitter_creator":"@Investcotedazur","twitter_site":"@Investcotedazur","twitter_misc":{"Written by":"Jose Perez Gabarron","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.investincotedazur.com\/en\/the-nice-based-biotech-company-roca-therapeutics-receives-financial-support-from-europe-and-the-sud-region-for-its-medical-research-in-eye-health\/#article","isPartOf":{"@id":"https:\/\/www.investincotedazur.com\/en\/the-nice-based-biotech-company-roca-therapeutics-receives-financial-support-from-europe-and-the-sud-region-for-its-medical-research-in-eye-health\/"},"author":{"name":"Jose Perez Gabarron","@id":"https:\/\/www.investincotedazur.com\/en\/#\/schema\/person\/ebbeede4229d29e0861488f2bd1036d9"},"headline":"The Nice-based biotech company Roca Therapeutics receives financial support from Europe and the SUD region for its medical research in eye health","datePublished":"2025-06-05T11:06:32+00:00","dateModified":"2025-09-05T07:25:31+00:00","mainEntityOfPage":{"@id":"https:\/\/www.investincotedazur.com\/en\/the-nice-based-biotech-company-roca-therapeutics-receives-financial-support-from-europe-and-the-sud-region-for-its-medical-research-in-eye-health\/"},"wordCount":538,"publisher":{"@id":"https:\/\/www.investincotedazur.com\/en\/#organization"},"articleSection":["Biotechnologies","Nice C\u00f4te d'Azur Metropolis","Startups"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.investincotedazur.com\/en\/the-nice-based-biotech-company-roca-therapeutics-receives-financial-support-from-europe-and-the-sud-region-for-its-medical-research-in-eye-health\/","url":"https:\/\/www.investincotedazur.com\/en\/the-nice-based-biotech-company-roca-therapeutics-receives-financial-support-from-europe-and-the-sud-region-for-its-medical-research-in-eye-health\/","name":"The Nice-based biotech company Roca Therapeutics receives financial support from Europe and the SUD region for its medical research in eye health - Invest in C\u00f4te d&#039;Azur","isPartOf":{"@id":"https:\/\/www.investincotedazur.com\/en\/#website"},"datePublished":"2025-06-05T11:06:32+00:00","dateModified":"2025-09-05T07:25:31+00:00","description":"Roca Therapeutics receives over \u20ac1.1 million under the FEDER-FSE+ program to develop a non-invasive eye drop for rare ocular diseases, supporting regional biomedical innovation.","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.investincotedazur.com\/en\/the-nice-based-biotech-company-roca-therapeutics-receives-financial-support-from-europe-and-the-sud-region-for-its-medical-research-in-eye-health\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.investincotedazur.com\/en\/#website","url":"https:\/\/www.investincotedazur.com\/en\/","name":"Invest in C\u00f4te d'Azur","description":"","publisher":{"@id":"https:\/\/www.investincotedazur.com\/en\/#organization"},"alternateName":"Invest in C\u00f4te d'Azur","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.investincotedazur.com\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.investincotedazur.com\/en\/#organization","name":"Invest in C\u00f4te d'Azur","alternateName":"Invest in C\u00f4te d'Azur","url":"https:\/\/www.investincotedazur.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.investincotedazur.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2023\/05\/cropped-New-missions-3.png","contentUrl":"https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2023\/05\/cropped-New-missions-3.png","width":512,"height":512,"caption":"Invest in C\u00f4te d'Azur"},"image":{"@id":"https:\/\/www.investincotedazur.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/investincotedazur\/","https:\/\/twitter.com\/Investcotedazur"]},{"@type":"Person","@id":"https:\/\/www.investincotedazur.com\/en\/#\/schema\/person\/ebbeede4229d29e0861488f2bd1036d9","name":"Jose Perez Gabarron","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.investincotedazur.com\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/20ec9e74f48620b8ee4253da6b114950?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/20ec9e74f48620b8ee4253da6b114950?s=96&d=mm&r=g","caption":"Jose Perez Gabarron"}}]}},"_links":{"self":[{"href":"https:\/\/www.investincotedazur.com\/en\/wp-json\/wp\/v2\/posts\/24518"}],"collection":[{"href":"https:\/\/www.investincotedazur.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.investincotedazur.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.investincotedazur.com\/en\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.investincotedazur.com\/en\/wp-json\/wp\/v2\/comments?post=24518"}],"version-history":[{"count":2,"href":"https:\/\/www.investincotedazur.com\/en\/wp-json\/wp\/v2\/posts\/24518\/revisions"}],"predecessor-version":[{"id":24520,"href":"https:\/\/www.investincotedazur.com\/en\/wp-json\/wp\/v2\/posts\/24518\/revisions\/24520"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.investincotedazur.com\/en\/wp-json\/wp\/v2\/media\/23390"}],"wp:attachment":[{"href":"https:\/\/www.investincotedazur.com\/en\/wp-json\/wp\/v2\/media?parent=24518"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.investincotedazur.com\/en\/wp-json\/wp\/v2\/categories?post=24518"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.investincotedazur.com\/en\/wp-json\/wp\/v2\/tags?post=24518"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}